|
Cannabis Campaigners' Guide News Database result:
|
|
UK: GW Pharmaceuticals in research collaboration with Israel's Prof Mechoulam
Etain Lavelle AFXnews.com
Wednesday 01 Jan 2003 LONDON (AFX) - GW Pharmaceuticals PLC said it has established an extensive research collaboration with one of the world's leading cannabinoid scientists, Professor Raphael Mechoulam of the Hebrew University of Jerusalem in Israel. Under the agreement, signed with the Research Development Company of the Hebrew University of Jerusalem, Yissum, GW has acquired the rights to a number of cannabinoid patents invented by Professor Mechoulam. GW Pharma, which is developing a portfolio of non-smoked, cannabis-based prescription medicines, said the patents include inventions relating to cannabidiol (CBD), one of the cannabinoids on which GW's research is focused, and endocannabinoids (cannabinoids found in the human body). Professor Mechoulam, who coined the term "cannabinoid", is the author of more than 270 publications and an inventor on over 21 patents, having worked on cannabinoid chemistry since the early 1960s. etain.lavelle@afxnews.com
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!